Fresenius Kidney Care-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Fresenius Kidney Care - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014340
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fresenius Kidney Care (FMCNA) , formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical information system, bloodlines and concentrates, home therapy products and others; its home therapy products include peritoneal dialysis products and home hemodialysis products. FMCNA offers services such as patient care, laboratory services, customer and technical support, courier services, education and training, managed care, billing, physician services, inpatient services and research services. The company has presence in Utah, and Walnut Creek, Ogden, California. FMCNA is headquartered in Waltham, Massachusetts, the US.

Fresenius Kidney Care – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fresenius Kidney Care, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Fresenius Kidney Care, Medical Devices Deals, 2011 to YTD 2017 9
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 11
Partnerships 12
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 12
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 13
Asset Transactions 14
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 14
Fresenius Kidney Care – Key Competitors 15
Fresenius Kidney Care – Key Employees 16
Fresenius Kidney Care – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Legal and Regulatory 18
Feb 22, 2016: Funding For Lawsuits Extends GranuFlo Lawsuit Funding 18
Other Significant Developments 19
Apr 13, 2016: Fresenius Medical Care North America’s Dialysis Division Is Now Fresenius Kidney Care 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Key Facts 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fresenius Kidney Care, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fresenius Kidney Care, Deals By Therapy Area, 2011 to YTD 2017 8
Fresenius Kidney Care, Medical Devices Deals, 2011 to YTD 2017 9
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 11
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 12
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 13
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 14
Fresenius Kidney Care, Key Competitors 15
Fresenius Kidney Care, Key Employees 16

★海外企業調査レポート[Fresenius Kidney Care-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Syndicate Bank Ltd (SYNDIBANK):企業の財務・戦略的SWOT分析
    Syndicate Bank Ltd (SYNDIBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Schneider Electric SE (SU):電力:M&Aディール及び事業提携情報
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line includes automation and control products, building management and securit …
  • Cyclopharm Ltd (CYC):企業の財務・戦略的SWOT分析
    Cyclopharm Ltd (CYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Polyplus-Transfection SA-製薬・医療分野:企業M&A・提携分析
    Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops its RNA interference such as STICKY SIRNA and SIRNAPLUS for invivo research. …
  • Asahi Kasei Corporation:企業のM&A・事業提携・投資動向
    Asahi Kasei Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Asahi Kasei Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Solent NHS Trust:企業の戦略的SWOT分析
    Solent NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Excision BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Excision BioTherapeutics Inc (Excision BioTherapeutics) is a developer of gene editing therapeutics for the treatment of infectious diseases. The company’s products comprise EBT101, a HIV CRISPR Cas9 gRNA multiplex biologic for the prevention of Human Immunodeficiency Virus; EBT103, a PML JC …
  • Royal Orchid Hotels Ltd
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Coats Group plc:企業のM&A・事業提携・投資動向
    Coats Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coats Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Internet Initiative Japan Inc (3774):企業の財務・戦略的SWOT分析
    Internet Initiative Japan Inc (3774) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • San Leon Energy Plc (SLE):企業の財務・戦略的SWOT分析
    Summary San Leon Energy Plc (San Leon) is an oil and gas exploration and production company. It is engaged in acquiring, exploring and developing conventional and shale oil and gas assets across Europe and North Africa. The company holds interests in Durresi Block located in offshore Albania and inc …
  • Xencor Inc (XNCR):企業の財務・戦略的SWOT分析
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company. It develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the t …
  • Ciena Corp (CIEN):企業の財務・戦略的SWOT分析
    Ciena Corp (CIEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Nisshin OilliO Group, Ltd.:企業の戦略・SWOT・財務情報
    The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gold Fields Limited:企業のM&A・事業提携・投資動向
    Gold Fields Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gold Fields Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Enbridge Energy Partners, L.P.:企業の戦略・SWOT・財務情報
    Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Diplomat Pharmacy Inc (DPLO):企業の財務・戦略的SWOT分析
    Diplomat Pharmacy Inc (DPLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • DalCor Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DalCor Pharmaceuticals Inc (DalCor Pharmaceuticals) researches and develops precision medicine for patients suffering from cardiovascular diseases. The company is engaged in development of Dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor which is intended to reduce cardiova …
  • Gran Tierra Energy Inc. (GTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Gran Tierra Energy Inc (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia. It sells oil t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆